Business Segments Mesa Laboratories, Inc.

Stocks

Market Closed - Nasdaq 01:30:00 15/08/2026 am IST			5-day change	1st Jan Change
106.04 ^USD	-6.33%		+3.30%	+35.08%

11/08	Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026
11/08	Mesa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Breakdown by Business Segment (USD)

Fiscal Period: March	2022	2023	2024	2025	2026
Medical Equipment
Sterilization and Disinfection Control	5.9Cr	6.46Cr	7.51Cr	9.34Cr	10Cr
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	4.37Cr	4.65Cr	5.33Cr	6.47Cr	7.17Cr
D&A	-	-	-	19.22L	23.05L
Medical Testing, Analyzing, and Diagnostic Equipment
Calibration Solutions	4.69Cr	4.48Cr	4.78Cr	5.17Cr	5.36Cr
Gross Profit	2.5Cr	2.44Cr	2.75Cr	3.06Cr	3.2Cr
D&A	-	-	-	8L	4L
Instruments	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Life Sciences Tools and Services
Biopharmaceutical Development	4.56Cr	4.74Cr	4.07Cr	4.87Cr	4.86Cr
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	2.86Cr	3.03Cr	2.54Cr	2.99Cr	2.86Cr
D&A	-	-	-	15.97L	18.2L
Clinical Genomics	3.28Cr	6.23Cr	5.26Cr	4.71Cr	4.54Cr
Gross Profit	1.19Cr	3.25Cr	2.71Cr	2.57Cr	2.6Cr
D&A	-	-	-	14.45L	13.43L
Plastic Packaging
Cold Chain Packaging	-	-	-	-	-
Total Assets	-	-	-	-	-
Gross Profit	-	-	-	-	-
Measuring, Analyzing, and Controlling Instruments
Continuous Monitoring	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Corporate and Other	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	-2L	-40T	-77T	-10T	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-

Geographical breakdown of sales (USD)

Fiscal Period: March	2022	2023	2024	2025	2026
United States	9.91Cr	12Cr	11Cr	12Cr	12Cr
Total Assets	3.65Cr	3.47Cr	3.22Cr	2.92Cr	2.99Cr
Other	-	7.6Cr	8.49Cr	9.91Cr	11Cr
Total Assets	-	-	24.79L	11.69L	12.13L
China	-	2.58Cr	2.49Cr	2.53Cr	2.04Cr
Total Assets	-	-	75.96L	67.12L	59.55L
Total Assets	-	-	-	1.16Cr	1.09Cr
Foreign	8.53Cr	-	-	-	-
Total Assets	39.75L	37.93L	-	-	-